Urinary tract infection N39.0

In 1808 Philip Syng referred to cystitis as "an inflammatory condition of the bladder with an ulcer producing the same symptoms as a bladder stone".

Joseph Parrish referred to urinary tract infection in 1836 as: "A painful tic of the urinary bladder" and Skene in 1887 as "An inflammation that has destroyed the mucous membrane partly or wholly and extended to the muscular parietes" (Bschleipfer 2018).

A urinary tract infection (UTI) is the presence of infectious agents in the urinary tract, which may present with or without symptoms (Herold 2020).

In the case of UTI, one differentiates between:

• symptomatic UTI
• recurrent UTI (≥ 2 infections within 6 months or ≥ 3 in a year)
• complicated UTI
  • any cystitis in children, men, pregnant women
  • with anatomical peculiarities
  • in case of functional peculiarities
  • If within the last 14 days:
    • a discharge from hospital or nursing home has occurred
    • a urinary catheter was inserted
    • an antibiosis has been administered
• uncomplicated UTI (in all other cases, the UTI is uncomplicated (Kuhlmann 2015).

In the literature, however, the terms "complicated" and "uncomplicated" are not treated consistently (Schmelz 2014).

• acute cystitis (acute inflammation of the lower urinary tract)
• pyelonephritis (symptomatic tubulointerstitial nephritis caused by UTI)
• Asymptomatic bacteriuria (asymptomatic colonization of the urinary tract with bacteria) (Herold 2020).

Up to the age of 50, UTI occurs almost exclusively in women. Approximately 60 % of all women suffer from a symptomatic UTI at least once in their lifetime. UTI is the most common nosocomial infection and is the most common cause of incapacity in women (Herold 2020). Among adult women, between 20%-30% develop acute cystitis ≥ 1 time per year (Schmelz 2014). The following peaks of illness are found in UTI:

1. in infancy and early childhood

2. during the honeymoon (so-called honeymoon cystitis)

3. during pregnancy

4. in the postpartum period: in women, the prevalence increases with age (Herold 2020). In men, HWIs occur only from about the age of 50 and are predominantly obstructive due to prostate disease (Kuhlmann 2015).

5. Z. n. kidney transplantation: UTI is the most common bacterial infection in patients with Z. n. kidney transplantation with 45% - 72% (Guberina 2016) (Keller 2010). In the 1st year after transplantation - especially in the first 3 - 6 months - HWIs occur frequently (Kuhlmann 2015).

Asymptomatic bacteriuria in women is found in:

• 5 % of premenopausal women
• 19 % of older women
• 27% of diabetic women (Herold 2020).

Among sexually active women between 20 - 45 years of age, symptomatic cystitis develops later in about 8%. In women without pre-existing asymptomatic bacteriuria, the prevalence of cystitis is only 1% (Manski 2019). Untreated asymptomatic bacteriuria in pregnant women leads to acute pyelonephritis in up to 30% (Herold 2020). Patients with indwelling catheters also frequently have asymptomatic bacteriuria, which also remains asymptomatic in the further course (Manski 2019).

In women, causal anatomical conditions play a major role such as:

• short urethra in direct localization to the anal region
• Cleaning of the intimate region from back to front instead of from front to back (Herold 2020).

In men, there is some protection against cystitis due to:

• longer urethra
• the dry meatus urethrae is only slightly colonized with germs (Keller 2010)

In approx. 50 % of HWIs bacteria are found as cause:

• Gram-negative pathogens such as:
  • 77 % Escherichia coli
  • 5 % Proteus mirabilis
  • 2 % - 3 % Klebsiella pneumoniae
  • 1 % Enterobacter spp.
  • < 1 % Citrobacter spp.
  • 2 % other Enterobacteriaceae
• Gram-positive pathogens such as:
  • 3 % Staphylococcus saprophyticus
  • 2 % Staphylococcus aureus
  • 4 % other Staphylococci
  • 3 % Enterococcus spp.
  • < 1 % Streptococcus spp. (Manski 2020)
• Trichomonads (rare)
• Candida (rare) (Herold 2020)

Uncomplicated UTI: Uncomplicated UTI is caused by E. coli in up to 80% of cases (Herold 2020).

Complicated UTI: In complicated UTI, enterococci are present in 30%, E. coli and staphylococci in 20% each, Pseudomonas aeruginosa in 10%, and Proteus mirabilis, Klebsiella, and other germs in < 5% each (Herold 2020).

UTI in patients after kidney transplantation: Gram-negative pathogens and enterococci are predominant (Kuhlmann 2015).

Nosocomial UTI: In the case of nosocomial UTI, mixed infections with problem germs such as:

• Enterococci
• Pseudomonas
• Proteus
• Enterobacter
• Citrobacter

In patients with permanent catheters, 50 % have a UTI after only 1 week, and almost 100 % after 1 month. These are predominantly mixed infections. Candida is found in the urine of approx. 20 %, but there are mostly no symptoms.

Risk factors for a urinary tract infection are:

• Urinary tract dysfunction due to
  • Anatomical anomalies in the area of the kidneys or the urinary tract.
    • Obstructions such as e.g. with
    • nephrolithiasis
    • (kidney) tumours
    • benign prostatic hypertrophy (BPH)
    • strictures in the area of the urethra
    • presence of urethral valves
  • Bladder dysfunction such as.
    • neurogenic disorders
    • paraplegia
    • vesico-uretero-renal reflux (is congenital in 40 %, w: m = 4: 1, may also be acquired due to innervation disorders of the urinary bladder or infravesical obstruction)
• nosocomial acquired by instrumentation of the urinary tract
• Disturbance of the immune defence due to e.g.
  • immunodeficiencies
  • immunosuppressive therapy
• analgesic abuse
• gravidity
• renal insufficiency
• Metabolic disorders such as
  • diabetes mellitus
  • Hypercalcemia
  • Hyperuricemia
  • Hypokalemia
• other factors such as
  • hypothermia
  • low urine output due to fluid loss or insufficient drinking
• recent sexual intercourse
• new sexual partners
• use of spermicides
• history of urinary tract infections
• anamnestic urinary tract infections in first-degree female relatives (Kuhlmann 2015).

All other factors such as pre- or post-coital urination, use of tampons, warm baths, showering behaviour, frequency of micturition, type of underwear, etc. have not yet been proven in studies (Kuhlmann 2015).

At the beginning of the inflammation, hyperemia, edema and infiltration of the bladder wall occur in the urinary bladder due to neutrophilic granulocytes. In the further course, the mucosa is replaced by an easily injured granulation tissue. Occasionally, shallow ulcers filled with exudate develop there. The inflammation usually affects only the mucosa and submucosa. All layers of the muscularis are rarely affected.

Without treatment, hemorrhages and necroses of the bladder wall occur in the late stage of the disease (Manski 2019).

UTI can present clinically in completely different ways:

Asymptomatic bacteriuria: This is usually an incidental finding. In this case - despite normal urine sediment and absence of symptoms - bacteriuria is detectable. There are no symptoms (Herold 2020).

Symptomatic U TI: In symptomatic UTI, a distinction is made between an uncomplicated and a complicated form and between different degrees of severity.

- Uncomplicated U TI: In this case, predisposing factors are usually absent and a monoinfection is present (for more details, see "Etiopathogenesis" above).

- Complicated U TI: In complicated UTI, predisposing risk factors are present and a mixed culture is present (for more details, see "Etiopathogenesis" above).

One differentiates between 3 degrees of severity:

• Grade I: There is no renal involvement.
• Grade II: There is renal involvement.
• Grade III: There is an irreversible obstruction of the outflow, e.g. permanent catheter, suprapubic urinary diversion (Herold 2020).

The cardinal symptoms in symptomatic UTI are (Mader 2019): dysuria, pollakiuria.

Acute cystitis: Acute cystitis usually starts suddenly. The cardinal symptoms are:

• Disorders of micturition such as:
  • Dysuria (difficult urination with weakened urine stream)
  • Alguria (pain during urination)
  • Pollakisuria (frequent urination with predominantly small amounts of urine)
  • nocturia (nocturnal urination)
• Pain in the suprapubic area

The following symptoms may also occur:

• Macrohaematuria
• turbidity of the urine
• altered odour of the urine
• new onset or increased incontinence (Herold 2020 / Manski 2019 / Keller 2010 / Kuhlmann 2015 / Schmelz 2014).

In renal transplant patients, UTI can be completely asymptomatic (Konik 2020).

The diagnosis depends on various factors and includes in V. a.:

Asymptomatic bacteriuria. In this case, screening should be done only in pregnant women.

Symptomatic UTI (except in healthy non-pregnant pre-menopausal women): Urine culture.

Complicated UTIs in men: urinalysis, sonography, prostate exam

Recurrent U TIs (Herold 2020): urine culture, one-time sonography

• in patients with haematuria or pathogens other than E. coli:
  • Urethrocystoscopy
  • further imaging

Acute cystitis: According to the S3 guideline of the DGU, no further diagnosis is necessary in the following cases (Manski 2019):

• with typical symptoms(pollakiuria, dysuria)
• WITHOUT genital fluoride
• renal bearings NOT palpable
• otherwise healthy, non-pregnant pre-menopausal women
• V. a. vaginitis or adnexitis:
  • vaginal examination
  • taking of swabs for microbacterial examination
• Micturition disorders:
  • micturition cystourethrography (MCU)

(for more details see below "Imaging" and "Laboratory")

ACSS- questionnaire: In 2015, Alidjanov et al. presented the ACSS- questionnaire (Acute Cystitis Symptom Score) to validate uncomplicated acute cystitisin women.

Sonography: On sonography of the urinary bladder and kidneys, there may be any evidence of (Manski 2019):

• anatomical norm variants
• diverticula of the urinary bladder
• Urinary bladder stones
• Urinary retention
• residual urine
• morphological changes of the kidneys in symptomatic UTI severity II (for details see above "Clinical picture")

Urogram: In case of recurrent cystitis that showed abnormalities on sonography (such as urinary retention, urinary bladder diverticulum, infectious stones, ureterocele, etc.), it is recommended to perform a urogram (Manski 2019).

Cystoscopy: Cystoscopy should be performed exclusively in the infection-free interval (Manski 2019). Routinely, according to the S3- guideline , it is not recommended in women without other relevant concomitant diseases, even in the case of recurrent urinary tract infections, but it is recommended above a certain age (not further defined) and in the case of complications such as microhematuria, detection of pathogens other than E. coli, etc.

Contrast-enhanced CT: If sonography reveals an unclear finding, CT is recommended. This can detect:

• obstructions (due to e.g. nephrolithiasis)
• anatomical anomalies
• radiological signs of chronic pyelonephritis such as:
  • Plumping of the renal calices
  • deformations of the renal calices
  • Narrowing of the parenchyma

MRI: MRI is indicated in patients with contrast allergy or to iodine-containing contrast agents (Herold 2020).

Micturition cystourethrography (MCU): Retrograde micturition cystourethrography can provide morphologic and functional information about the lower urinary tract (Sigel 2013). Indications include:

• micturition disorders (especially in children)
• sonographically proven dilatation of the upper urinary tract
• Residual urine formation
• V. a. vesicoureteral reflux (VUR)

Blood test: Blood tests are not usually necessary for uncomplicated UTI, but are necessary for suspected pyelonephritis. If sepsis is suspected, blood cultures should be obtained immediately. Symptomatic UTI of severity II or higher may cause renal function impairment (see "Clinical picture" above for details), which can be detected by laboratory tests (Herold 2020).

Urine test strip: A positive test strip increases the likelihood of cystitis. However, since both sensitivity and specificity are insufficient, the test strip is not recommended for the diagnosis of cystitis according to the S3- guideline (Wagenlehner 2017).

Urine sediment: Nowadays, automated sediment analysis (with particle counter) is increasingly used (Wagenlehner 2017). This can be used to detect bacteriuria, micro- or macrohematuria, pyuria, and positive nitrite in the presence of high bacterial counts (Manski 2019).

1. bacteriuria: urine should be obtained before starting antibiotics.

The prerequisites for correct collection are spreading of the labia, careful cleaning of the meatus urethrae or glans penis. Subsequently, midstream urine can be obtained. Prerequisites for the correct interpretation of the findings are rapid transport by cold chain, the use of special media or immediate processing.

As a general rule, urine should not be collected from catheter bags for further examination (Herold 2020).

1a. Midstream urine: According to Kass, one speaks of a significant bacteriuria if a bacterial count of ≥ 105 / ml urine is found in the midstream urine after appropriate processing. Lower bacterial counts indicate contamination.

An exception is made for patients with typical symptoms of a UTI who have been treated. Here, bacterial counts ≤103 to 104 / ml urine are also considered pathological (Herold 2020).

1b. Bladder puncture urine: In urine obtained by bladder puncture, any detection of germs is considered pathological.

In cases of recurrent HWIs with evidence of enterococci or a mixed infection in midstream urine, bladder puncture is recommended because contamination is often present (Herold 2020)

For any significant bacteriuria (definition see above 1a. and 1b.), a germ differentiation with antibiogram should be created (Herold 2020).

Leukocyturia: leukocyturia is an indication of pyelonephritis: leukocyturia in otherwise sterile urine (so-called sterile leukocyturia) can be caused by:

• a UTI treated with antibiotics
• genital contamination (e.g. by fluorine)
• urethritis (e.g. by mycoplasma or chlamydia)
• urogenital tuberculosis
• Reiter's syndrome (in this case there is a triad of urethritis, conjunctivitis, arthritis)
• Gonorrhea
• Analgesic anphropathy (Herold 2020)

Urine culture: Urine culture is recommended for:

• Men
• pregnant women
• postmenopausal women
• diabetes mellitus
• after unsuccessful antibiosis
• in the presence of cystitis with e.g.:
  • Congenital anatomical changes (e.g., ureteral outlet stenosis, phimosis, urinary bladder diverticulum, etc. [Kuhlmann 2015])
  • Acquired anatomical changes (e.g. nephrolithiasis, prostate enlargement, urinary bladder tumors, pregnancy, etc. [Kuhlmann 2015])
  • Functional disorders (e.g., renal insufficiency, voiding disorders of the bladder, urinary transport disorders, etc. [Kuhlmann 2015])
  • Immunity disorders (e.g., diabetes mellitus, HIV, liver failure, immunodeficiencies, etc. [Kuhlmann 2015])
  • Intraoperative or postoperative dysregulation or foreign bodies (e.g., nephrostomy, bladder catheter, ureteral stent [Kuhlmann 2015]) (Manski 2019)
• benign prostatic hypertrophy
• (chronic) interstitial cystitis
• paracytic cystitis due to infection with Schistosoma haematobium
• tuberculous cystitis
• caused by other diseases such as:
• Prostatitis
• intestinal diseases
• adnexitis
• drug-induced cystitis caused by e.g.:
• Ifosfamide
• Cyclophosphamide
• NSAID
• caused by other bladder diseases such as lithiasis, tumor, foreign body
• cystitis caused by radiation (so-called radiogenic cystitis)
• heart failure (Herold 2020)
• genital herpes
• gonorrhea
• neurogenic bladder disorder
• psychosomatic complaints (Manski 2019)
• Urethritis (insidious onset, vaginal fluor, herpetic lesions, etc.; inflammation here is distal to the sphincter urethrae internus [Herold 2020])
• Vaginitis (vaginal fluor, itching, odor, etc.) (Schmelz 2014).

For a urine culture, midstream urine is required (see "Urine sediment" above). Pathogen counts of > 105 germs / ml indicate cystitis. A bacterial count of 103 to 104 germs / ml is already relevant if clinical symptoms are present at the same time. It should be noted that forced diuresis can also result in falsely low bacterial counts. The detection of pathogens in a urine sample obtained by bladder puncture or disposable catheterization is always considered pathological. In permanent catheter users, a bacterial count of > 104 plus leukocyturia of > 100 / µg is considered a significant infection (Manski 2019).

Recurrent cystitis (Herold 2020).

Hematuria to macrohematuria (Kasper 2015).

Pyelonephritis due to ascension of pathogens. Occurs in < 5% of all patients with acute cystitis (Manski 2019 / Schmelz 2014)

paranephritic abscess (CT).

In pregnant women:

• Pyelonephritis due to ascension of the pathogens in up to 23 % . This can be complicated by concomitant
  • Anemia (23 %)
  • renal dysfunction (7 %)
  • respiratory insufficiency (7 %)
• Pyelonephritis can lead to in pregnant women ((Manski 2019):
  • Prematurity
  • reduced birth weight
  • increased neonatal mortality
  • pre-eclampsia

Asymptomatic detection of germs:

The following patients with asymptomatic detection of germs do not require screening or antibiotic treatment:

• non-pregnant women in premenopause
• diabetics with a stable metabolic situation
• elderly persons living in a home
• elderly persons living at home
• patients with permanent catheter in situ
• patients with post spinal cord injuries
• patients before orthopaedic surgery
• in young men with asymptomatic bacteriuria and without relevant concomitant diseases (Wagenlehner 2017)
• Women at no risk in the postmenopausal period (Manski 2019).

Treatment of asymptomatic bacteriuria is always required in:

• Pregnant women
• transplanted patients
• immunocompromised patients
• Urinary obstructions
• before transurethral prostate resection (Herold 2020)

Symptomatic germ detection. If the course is mild, it may be possible to wait with antibiotics (initially). The patient should be advised to

• drink plenty of fluids
• warm sitz baths
• analgesics
• anticholinergics

If there is no improvement under this, antibiotic treatment is required (Manski 2019).

Uncomplicated acute cystitis in women can be treated with short-term oral antibiotic therapy (1 - 3 days).

The S3- guideline primarily recommends agents that show a low resistance rate, do not play a role in severe infections, and are sensitive to the typical pathogen spectrum in women in Germany.

The 1st choice agents include:

• Fosfomycin- Trometamol (e.g. Monuril). It shows a sensitivity of 96 % and leads to a development of resistance in 1 %. However, from a GFR of < 20 ml / min / 1.73 m² KOF, fosfomycin- trometamol is contraindicated. Dosage recommendation: 3,000 mg 1 x as a single dose.
• Nitrofurantoin: Sensitivity is 86%, development of resistance is 5%. Nitrofurantoin is contraindicated in renal insufficiency from < 60 ml / min / 1.73 m² KOF. Dosage recommendation: 50 mg 4 x / d for 7 days or or nitrofurantoin ret. 100 mg 2 x 1 for 7 days.
• Nitroxolin: Nitroxolin is also contraindicated in severe renal dysfunction (serum creatinine > 2.0 mg / dl). Recommended dosage: 250 mg 3 x / d over 5 days.

In uncomplicated cystitis (see "Classification") should NOT be used as a 1st choice agent:

• Ciprofloxacin: sensitivity is 92%, resistance development is 7%. Dose adjustment required above a GFR of < 60 ml / min / 1.73 m² KOF. Recommended dosage: 250 mg 2 x / d for 3 days.
• Cotrimoxazole: sensitivity is 74 %, resistance development is 26 %. For cotrimoxazole, dose adjustment is required from a GFR of < 30 ml / min / 1.73 m² KOF. From < 15 ml / min / 1.73 m² KOF, the drug is contraindicated. Recommended dosage: 160 / 800 mg 2 x / d for 3 days.

The 3rd choice agents (due to side effects) include:

• Fluoroquinolones such as levofloxacin. The development of resistance is 30 %. In this case, dose adjustment is required from a GFR of < 50 ml / min / 1.73 m² KOF. Dosage recommendation: 250 mg 1 x / d for 3 days (Wagenlehner 2017 / Manski 2019 / Herold 2020).

(Complicated) acute cystitis in pregnant women: In pregnancy, even asymptomatic bacteriuria should be treated with antibiotics, otherwise the risk of complications (see above "Complications") increases. Antibiotics that can be used are:

• Fosfomycin- Trometamol (e.g. Monuril). It shows a sensitivity of 96 % and leads to a development of resistance in 1 %. However, from a GFR of < 20 ml / min / 1.73 m² KOF, fosfomycin- trometamol is contraindicated. Dosage recommendation: 3,000 mg 1 x as a single dose.

• Pivmecillinam (e.g. X- Systo). From a GFR of < 30 ml / min / 1.73 m² KOF, a dose adjustment is required. Dosage recommendation: 400 mg 3 x / d for 3 days (Manski 2019).

(Complicated) cystitis in postmenopausal women: There are few studies that have investigated the efficacy of short-term therapy in postmenopausal women. The choice and efficacy of each antibiotic is similar to that of uncomplicated premenopausal UTI, but the duration of therapy should be extended if necessary.

• Fosfomycin- Trometamol (e.g. Monuril). An uncontrolled study of single dose showed viral elimination of 87% and clinical efficacy of 96% in postmenopausal women. However, above a GFR of < 20 ml / min / 1.73 m² KOF, fosfomycin- trometamol is contraindicated. Dosage recommendation: 3,000 mg 1 x as a single dose.

• Ciprofloxacin. Sensitivity is 92%, development of resistance is 7%. Dose adjustment required above a GFR of < 60 ml / min / 1.73 m² KOF. Dosage recommendation: 250 mg 2 x / d. Here, a study in postmenopausal women demonstrated the equivalence of a 3- or 6-day treatment, showing better tolerability with the short therapy (Kuhlmann 2015).

(Complicated) acute cystitis in younger men: Since this occurs only very rarely, there are few meaningful comparative studies. In symptomatic cystitis, oral drug treatment with the following antibiotics is recommended - after obtaining a urine culture - (and adjusted if necessary after obtaining the antibiogram):

• Pivmecillinam: The sensitivity is 98% and the development of resistance is 1% (Manski 2019).Dosage recommendation: 400 mg 2 - 3 x / d for7 - 10 days.
• Nitrofurantoin: Here the sensitivity is 86 % and resistance is 5 % (Manski 2019). Dosage recommendation: 50 mg 4 x / d for 7 - 10 days. Nitrofurantoin should not be used in the presence of prostate involvement (Wagenlehner 2017).
• Fluoroquinolones: Fluoroquinolones can be used as long as the resistance rate for local E. coli is still < 10 %. The sensitivity is 92 %, the resistance 7 %. Dose adjustment is required from a GFR of < 50 ml / min / 1.73 m² KOF. Dosage recommendation: e.g. ciprofloxacin 250 mg 2 x / d . Duration of therapy: 7 - 10 days (so far, studies have not been able to prove that a short therapy is as effective in men as in women) (Wagenlehner 2017 / (Manski 2019).

It remains open - according to the S3- guideline - whether a complete urological examination should be performed in uncomplicated cystitis in younger men. In any case, this is recommended in:

• febrile cystitis
• recurrent cystitis
• V. a. complicating factors
• V. a. chronic bacterial prostatitis (Wagenlehner 2017)

UTI in patients with kidney transplantation:

Asymptomatic bacteriuria: The question whether asymptomatic bacteriuria after kidney transplantation should be treated with antibiotics is controversial. Retrospective studies have shown that asymptomatic bacteriuria correlates with high rejection rates. Therefore, it is recommended to treat patients with antibiotics during the first 1-3 months. However, a recent prospective randomized study of 112 transplanted patients (Origüen 2016) failed to demonstrate a clear benefit.(Guberina 2016).

UTI: U TIs are more common in patients with renal transplantation, simply because of immunosuppression (Guberina 2016). Pyelonephritis can lead to a significant deterioration in graft function, which is only partially reversed even after successful treatment (Kuhlmann 2015). If a UTI occurs immediately after transplantation, initial parenteral antibiotics appropriate to resistance are required. Further treatment can be oral and should continue for at least 6 weeks (Keller 2010). Within the first 3 months after transplantation, 6 weeks of oral therapy is recommended according to the antibiogram. If an UTI occurs later than 6 months after transplantation, a 10-14 day treatment period is usually sufficient (Keller 2010). In the case of symptomatic UTI, the initiation of antibiotics is recommended from > 103 germs / ml. After the urine culture has been taken, the following antibiotics can be administered:

In mild cases e.g.:

• Ciprofloxacin: Sensitivity is 92%, resistance development is 7% Dose adjustment required from a GFR of < 60 ml / min / 1.73 m² KOF. Dosage recommendation: 250 mg 2 x / d. After adjustment of the antibiotic according to the antibiogram, the duration of treatment should be at least another 5 - 7 days (Kuhlmann 2015).

For severe infections, e.g.:

• Piperacillin / Tazobactam: dosage recommendation: 4.5 g 3 x / d (Bschleipfer 2018). Antibiotic treatment should be given for 14 - 21 days in severe cases (Kuhlmann 2015).

For multidrug-resistant bacteria, e.g:

• Vancomycin, dosage recommendation: 2 x 1 g / d i. v., then dose adjustment according to valley level (Keller 2010). The antibiotic treatment should also be given for 14 - 21 days (Kuhlmann 2015).

____________________________________________________________________________________________

"Essen algorithm for the calculated antibiotic treatment of urinary tract infections in kidney transplant patients".

The algorithm was first presented in 2011 for the calculated antibiotic treatment of kidney transplant patients. It considers gram-negative germs in addition to enterococci occurring in the early phase. It recommends the use of quinolones (gyrase inhibitors) in the first two months after transplantation and then cephalosporins from the third month onwards. Treatment should be started parenterally in cases of severe infection and continued orally (Becker 2011).

_____________________________________________________________________________________________

UTI with Candida:

Treatment of asymptomatic candiduria is recommended only when

• neutropenia is present
• urological surgery is imminent

For susceptible Candida species, treatment should be with:

• Fluconazole 200 mg - 400 mg /d orally for 14 days.
• Alternatively, bladder irrigation with 50 mg amphotericin B / l water for 5 - 7 days may be used. In this case, however, the success is unclear (Kuhlmann 2015).

The spontaneous healing rate of an uncomplicated UTI is between 30 % - 50 % within one week (Herold 2020). In the case of a UTI treated with antibiotics, the following symptoms should appear after 24 hours:

• resolution of any fever that may be present
• Improvement of the clinical symptoms

The urine should be sterile again after 3 days. If this is not the case, there are probably complications (see above / Herold 2020).

The prognosis of HWI treated with antibiotics is good overall. In recurrent UTIs, the risk of transition to chronic pyelonephritis (CPN) is relatively low, provided there are no predisposing factors such as vesicoureteral reflux, obstruction, etc.

For the prevention of recurrent cystitis are recommended:

• Increase the amount of drinking to 1.5 - 2 l / d
• avoidance of obesity (obesity increases the risk by a factor of 2.5 - 5)
• regular consumption of cranberry juice (cranberries)
• no excessive genital hygiene (e.g. intimate sprays, bidet rinses etc.)
• Vaccination
  • oral administration of inactivated, immunogenic E. coli strains (e.g. Uro- Vaxom); dosage recommendation: 1 capsule / d over 3 months
  • intramuscular vaccination, e.g. with Strovac or Perison: a total of 3 injections at intervals of 2 weeks each for basic immunisation, a booster vaccination after one year
• D- mannose 2 g / d (the excretion of mannose occupies the fimbriae of coliform bacteria and reduces adherence to the urothelium)
• vaginal estrogenization

Recurrent urinary tract infections in postmenopausal women can be reduced by vaginal estrogen replacement therapy in the form of ointment, capsule or ring

• Antibiotic prophylaxis: In patients with high distress or complications, antibiotic administration in the evening (alternatively after sexual intercourse) is recommended. The choice of antibiotic should primarily be based on the previous bacterial species and their sensitivity to antibiotics. Otherwise, come into question: eg, 50 mg - 100 mg / d nitrofurantoin or cotrimoxazole240 mg - 480 mg / d over 3 - 6 months (Manski 2019 / Herold 2020 /Wagenlehner 2017).

Uvae ursi folium, Ononidis radix, Vaccinii macrocarpon fructus, Betulae folium, Armoraciae rusticanae radix, Solidaginis herba, Pyri communis folium

see also under Fenchon, Colocynthidis fructus, Barosmae folium, Asparagi rhizoma

1. Alidjanov J F et al (2017) New questionnaire for German validation of the "Acute Cystitis Symptom Score". Urologist (56) 364 - 366
2. Becker S et al (2011) Urinary tract infections after kidney transplantation. The Urologist (50) 53 - 56
3. Bschleipfer T et al. (2018) Guideline group S2K guideline for interstitial cystitis (IC/BPS) long version, 1st edition, version 1, 2018. AWMF register no: 043/050.
4. Guberina H et al. Infections in immunosuppressed patients. Nephrologist 11 (6) 388 - 395
5. Herold G et al (2020) Internal medicine. Herold Publishers 617 - 622
6. Kasper D L et al (2015) Harrison's Principles of Internal Medicine. Mc Graw Hill Education 294
7. Keller C K et al (2010) Practice of nephrology. Springer Verlag 60 - 66, 77
8. Konik M et al (2020) Diagnosis and therapy of urinary tract infections. The Nephrologist (15) 233 - 239
9. Kuhlmann U et al. (2015) Nephrology: pathophysiology - clinic - renal replacement procedures. Thieme Verlag 542 - 548, 790 - 791
10. Mader F H et al. (2019) Programmed diagnostics in general medicine: 92 checklists according to Braun for anamnesis, examination and documentation. Springer Verlag 173
11. Manski D (2019) The urology textbook. Dirk Manski Publishers 348 - 352
12. Origüen J et al. (2016) Should Asymptomatic Bacteriuria Be Systematically Treated in Kidney Transplant Recipients? Results From a Randomized Controlled Trial. Am J Transplant. 16 (10) 2943 – 2953
13. Schmelz H U et al. (2014) Specialist examination in urology: 1000 documented examination questions. Georg Thieme Verlag 117 - 120
14. Sigel A et al (2013) Pediatric urology. Springer Verlag 44 - 45
15. Sökeland J et al (2008) Pocket textbook of urology. Georg Thieme Verlag 7.1.3.1.
16. Wagenlehner F et al. (2017) Interdisciplinary S3 guideline epidemiology, diagnosis, therapy, prevention and management of uncomplicated, bacterial, community-acquired urinary tract infections in adult patients update 2017. AWMF register no. 043/044.